Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Rev Esp Enferm Dig ; 115(4): 196-197, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-35899693

RESUMEN

We have written a "letter to Editor" about a case of gastric dilatation caused by a symptomatic gastric duplication cyst with ectopic pancreas ingrowth, in a 13 years old boy. The Endoscopy Ultra Sound characterized the lesion and permitted the aspiration of the internal liquid. The patient underwent to laparoscopic excision of the mass and the histology revealed a gastric duplication cyst with ectopic pancreas ingrowth.


Asunto(s)
Quistes , Dilatación Gástrica , Laparoscopía , Masculino , Humanos , Adolescente , Quistes/complicaciones , Quistes/diagnóstico por imagen , Quistes/cirugía , Dilatación Gástrica/diagnóstico por imagen , Dilatación Gástrica/etiología , Dilatación Gástrica/cirugía , Endosonografía , Páncreas
2.
J Infect ; 78(1): 1-7, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30336176

RESUMEN

OBJECTIVES: The main objective of this manuscript is to discuss our present knowledge of the relationships between dysbiosis and paediatric Crohn's disease (CD). The therapeutic role of the methods currently used to re-establish normal gut microbiota composition is also analysed. METHODS: PubMed was used to search for all of the studies published from January 2008 to June 2018 using the key words: "Crohn's disease" and "gut dysbiosis" or "microbiota" or "microbioma" or "probiotic" and "children" or "paediatric". More than 100 articles were found, but only those published in English or providing evidence-based data were included in the evaluation. RESULTS: Gut microbiota are primary actors in CD's pathogenesis. The new techniques developed in metagenomics allow us to reveal new details of microbiota composition in healthy subjects and CD patients, and to elucidate the link between microbiota and numerous pathologies, such as obesity, allergies and type 1 diabetes mellitus. CONCLUSION: Discoveries on the role of gut microbiota could potentially disclose new therapeutic options for CD treatment and improve the existing therapies. Further studies are needed to facilitate the diagnosis and tailor the therapy of a pathology that is an increasing burden on public health.


Asunto(s)
Enfermedad de Crohn/microbiología , Disbiosis , Tracto Gastrointestinal/microbiología , Autofagia , Niño , Enfermedad de Crohn/fisiopatología , Enfermedad de Crohn/terapia , Microbioma Gastrointestinal , Humanos , Metagenómica , Probióticos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA